Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02081378
Title A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals

chronic myeloid leukemia

acute lymphoblastic leukemia



Asciminib + Imatinib

Asciminib + Dasatinib

Asciminib + Nilotinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU

Additional content available in CKB BOOST